Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 86

1.

Reply.

Risseeuw S, Ossewaarde-van Norel J, Klaver CCW, Colijn JM, Imhof SM, van Leeuwen R.

Retina. 2019 Jan;39(1):e8. doi: 10.1097/IAE.0000000000002428. No abstract available.

PMID:
30570624
2.

High-Dimensional Profiling Reveals Heterogeneity of the Th17 Subset and Its Association With Systemic Immunomodulatory Treatment in Non-infectious Uveitis.

Verhagen FH, Hiddingh S, Rijken R, Pandit A, Leijten E, Olde Nordkamp M, Ten Dam-van Loon NH, Nierkens S, Imhof SM, de Boer JH, Radstake TRDJ, Kuiper JJW.

Front Immunol. 2018 Oct 31;9:2519. doi: 10.3389/fimmu.2018.02519. eCollection 2018.

3.

Aqueous Humor Analysis Identifies Higher Branched Chain Amino Acid Metabolism as a Marker for Human Leukocyte Antigen-B27 Acute Anterior Uveitis and Disease Activity.

Verhagen FH, Stigter ECA, Pras-Raves ML, Burgering BMT, Imhof SM, Radstake TRDJ, de Boer JH, Kuiper JJW.

Am J Ophthalmol. 2019 Feb;198:97-110. doi: 10.1016/j.ajo.2018.10.004. Epub 2018 Oct 9.

PMID:
30312576
4.

VISUAL ACUITY IN PSEUDOXANTHOMA ELASTICUM.

Risseeuw S, Ossewaarde-van Norel J, Klaver CCW, Colijn JM, Imhof SM, van Leeuwen R.

Retina. 2018 Apr 12. doi: 10.1097/IAE.0000000000002173. [Epub ahead of print]

PMID:
29652691
5.

Etidronate for Prevention of Ectopic Mineralization in Patients With Pseudoxanthoma Elasticum.

Kranenburg G, de Jong PA, Bartstra JW, Lagerweij SJ, Lam MG, Ossewaarde-van Norel J, Risseeuw S, van Leeuwen R, Imhof SM, Verhaar HJ, de Vries JJ, Slart RHJA, Luurtsema G, den Harder AM, Visseren FLJ, Mali WP, Spiering W.

J Am Coll Cardiol. 2018 Mar 13;71(10):1117-1126. doi: 10.1016/j.jacc.2017.12.062.

PMID:
29519353
6.

Flexibility in Postgraduate Medical Training in the Netherlands.

Hoff RG, Frenkel J, Imhof SM, Ten Cate O.

Acad Med. 2018 Mar;93(3S Competency-Based, Time-Variable Education in the Health Professions):S32-S36. doi: 10.1097/ACM.0000000000002078.

PMID:
29485485
7.

A Disease-Associated MicroRNA Cluster Links Inflammatory Pathways and an Altered Composition of Leukocyte Subsets to Noninfectious Uveitis.

Verhagen FH, Bekker CPJ, Rossato M, Hiddingh S, de Vries L, Devaprasad A, Pandit A, Ossewaarde-van Norel J, Ten Dam N, Moret-Pot MCA, Imhof SM, de Boer JH, Radstake TRDJ, Kuiper JJW.

Invest Ophthalmol Vis Sci. 2018 Feb 1;59(2):878-888. doi: 10.1167/iovs.17-23643.

PMID:
29435587
8.

Prevalence and characteristics of ocular pain in non-infectious uveitis: a quality of life study.

Verhagen FH, Wijnhoven R, Ossewaarde-van Norel J, Ten Dam-van Loon NH, Kuiper JJW, Imhof SM, de Boer JH.

Br J Ophthalmol. 2018 Aug;102(8):1160-1166. doi: 10.1136/bjophthalmol-2017-311575. Epub 2018 Jan 29.

PMID:
29378727
9.

Cost-Effectiveness Analysis of Corneal Collagen Crosslinking for Progressive Keratoconus.

Godefrooij DA, Mangen MJ, Chan E, O'Brart DPS, Imhof SM, de Wit GA, Wisse RPL.

Ophthalmology. 2017 Oct;124(10):1485-1495. doi: 10.1016/j.ophtha.2017.04.011. Epub 2017 May 19.

PMID:
28532974
10.

Age-specific Incidence and Prevalence of Keratoconus: A Nationwide Registration Study.

Godefrooij DA, de Wit GA, Uiterwaal CS, Imhof SM, Wisse RP.

Am J Ophthalmol. 2017 Mar;175:169-172. doi: 10.1016/j.ajo.2016.12.015. Epub 2016 Dec 28.

PMID:
28039037
11.

Visual outcome in Sturge-Weber syndrome: a systematic review and Dutch multicentre cohort.

Koenraads Y, van Egmond-Ebbeling MB, de Boer JH, Imhof SM, Braun KP, Porro GL; SWS study group.

Acta Ophthalmol. 2016 Nov;94(7):638-645. doi: 10.1111/aos.13074. Epub 2016 May 30. Review.

12.

Nationwide reduction in the number of corneal transplantations for keratoconus following the implementation of cross-linking.

Godefrooij DA, Gans R, Imhof SM, Wisse RP.

Acta Ophthalmol. 2016 Nov;94(7):675-678. doi: 10.1111/aos.13095. Epub 2016 May 23.

13.

Systemic inflammatory immune signatures in a patient with CRB1 linked retinal dystrophy.

Verhagen F, Kuiper J, Nierkens S, Imhof SM, Radstake T, de Boer J.

Expert Rev Clin Immunol. 2016 Dec;12(12):1359-1362. Epub 2016 Oct 6.

PMID:
27690673
14.

Higher-order aberrations 1 year after corneal collagen crosslinking for keratoconus and their independent effect on visual acuity.

Wisse RP, Gadiot S, Soeters N, Godefrooij DA, Imhof SM, van der Lelij A.

J Cataract Refract Surg. 2016 Jul;42(7):1046-52. doi: 10.1016/j.jcrs.2016.04.021.

PMID:
27492104
15.

CRISPR/Cas9-Mediated Genome Editing of Herpesviruses Limits Productive and Latent Infections.

van Diemen FR, Kruse EM, Hooykaas MJ, Bruggeling CE, Schürch AC, van Ham PM, Imhof SM, Nijhuis M, Wiertz EJ, Lebbink RJ.

PLoS Pathog. 2016 Jun 30;12(6):e1005701. doi: 10.1371/journal.ppat.1005701. eCollection 2016 Jun.

16.

Predictors for treatment outcomes after corneal crosslinking for keratoconus: a validation study.

Godefrooij DA, Boom K, Soeters N, Imhof SM, Wisse RP.

Int Ophthalmol. 2017 Apr;37(2):341-348. doi: 10.1007/s10792-016-0262-z. Epub 2016 May 24.

17.

Comparison of Diaton transpalpebral tonometer with applanation tonometry in keratoconus.

Wisse RP, Peeters N, Imhof SM, van der Lelij A.

Int J Ophthalmol. 2016 Mar 18;9(3):395-8. doi: 10.18240/ijo.2016.03.12. eCollection 2016.

18.

Trends in penetrating and anterior lamellar corneal grafting techniques for keratoconus: a national registry study.

Godefrooij DA, Gans R, Imhof SM, Wisse RP.

Acta Ophthalmol. 2016 Aug;94(5):489-93. doi: 10.1111/aos.13041. Epub 2016 Apr 7.

19.

Corneal Cross-Linking for Pediatric Keratoconus: Long-Term Results.

Godefrooij DA, Soeters N, Imhof SM, Wisse RP.

Cornea. 2016 Jul;35(7):954-8. doi: 10.1097/ICO.0000000000000819.

PMID:
27027921
20.

Objective and subjective evaluation of the performance of medical contact lenses fitted using a contact lens selection algorithm.

Visser ES, Wisse RP, Soeters N, Imhof SM, Van der Lelij A.

Cont Lens Anterior Eye. 2016 Aug;39(4):298-306. doi: 10.1016/j.clae.2016.02.006. Epub 2016 Feb 23.

PMID:
26917334
21.

Ocular Fluid Analysis in Children Reveals Interleukin-29/Interferon-λ1 as a Biomarker for Juvenile Idiopathic Arthritis-Associated Uveitis.

Haasnoot AM, Kuiper JJ, Hiddingh S, Schellekens PA, de Jager W, Imhof SM, Radstake TR, de Boer JH.

Arthritis Rheumatol. 2016 Jul;68(7):1769-79. doi: 10.1002/art.39621.

22.

Reply: To PMID 25703475.

Soeters N, Wisse RP, Godefrooij DA, Imhof SM, Tahzib NG.

Am J Ophthalmol. 2015 Aug;160(2):400. doi: 10.1016/j.ajo.2015.05.023. No abstract available.

PMID:
26187889
23.

Scleral lens influence on corneal curvature and pachymetry in keratoconus patients.

Soeters N, Visser ES, Imhof SM, Tahzib NG.

Cont Lens Anterior Eye. 2015 Aug;38(4):294-7. doi: 10.1016/j.clae.2015.03.006. Epub 2015 Apr 10.

PMID:
25865408
24.

Transepithelial versus epithelium-off corneal cross-linking for the treatment of progressive keratoconus: a randomized controlled trial.

Soeters N, Wisse RP, Godefrooij DA, Imhof SM, Tahzib NG.

Am J Ophthalmol. 2015 May;159(5):821-8.e3. doi: 10.1016/j.ajo.2015.02.005. Epub 2015 Feb 19.

PMID:
25703475
25.

Perimetry in young and neurologically impaired children: the Behavioral Visual Field (BEFIE) Screening Test revisited.

Koenraads Y, Braun KP, van der Linden DC, Imhof SM, Porro GL.

JAMA Ophthalmol. 2015 Mar;133(3):319-25. doi: 10.1001/jamaophthalmol.2014.5257.

PMID:
25541916
26.

Visual function and compensatory mechanisms for hemianopia after hemispherectomy in children.

Koenraads Y, van der Linden DC, van Schooneveld MM, Imhof SM, Gosselaar PH, Porro GL, Braun KP.

Epilepsia. 2014 Jun;55(6):909-17. doi: 10.1111/epi.12615. Epub 2014 Apr 22.

27.

A multivariate analysis and statistical model for predicting visual acuity and keratometry one year after cross-linking for keratoconus.

Wisse RP, Godefrooij DA, Soeters N, Imhof SM, Van der Lelij A.

Am J Ophthalmol. 2014 Mar;157(3):519-25.e1-2. doi: 10.1016/j.ajo.2013.11.001. Epub 2013 Nov 6.

PMID:
24211861
28.

Impact of ocular graft-versus-host disease on visual quality of life in patients after allogeneic stem cell transplantation: questionnaire study.

Riemens A, Te Boome LC, Kalinina Ayuso V, Kuiper JJ, Imhof SM, Lokhorst HM, Aniki R.

Acta Ophthalmol. 2014 Feb;92(1):82-7. doi: 10.1111/aos.12047. Epub 2013 Apr 22.

29.

RB1 mutations and second primary malignancies after hereditary retinoblastoma.

Dommering CJ, Marees T, van der Hout AH, Imhof SM, Meijers-Heijboer H, Ringens PJ, van Leeuwen FE, Moll AC.

Fam Cancer. 2012 Jun;11(2):225-33. doi: 10.1007/s10689-011-9505-3.

30.

Single-shot turbo spin-echo diffusion-weighted imaging for retinoblastoma: initial experience.

de Graaf P, Pouwels PJ, Rodjan F, Moll AC, Imhof SM, Knol DL, Sanchez E, van der Valk P, Castelijns JA.

AJNR Am J Neuroradiol. 2012 Jan;33(1):110-8. doi: 10.3174/ajnr.A2729. Epub 2011 Oct 27.

31.

[Increase in the demand for eye-care services in the Netherlands 2010-2020].

Keunen JE, Verezen CA, Imhof SM, van Rens GH, Asselbergs MB, Limburg JJ.

Ned Tijdschr Geneeskd. 2011;155(41):A3461. Dutch.

PMID:
22008156
32.

Reproductive behavior of individuals with increased risk of having a child with retinoblastoma.

Dommering CJ, Garvelink MM, Moll AC, van Dijk J, Imhof SM, Meijers-Heijboer H, Henneman L.

Clin Genet. 2012 Mar;81(3):216-23. doi: 10.1111/j.1399-0004.2011.01791.x. Epub 2011 Oct 22.

PMID:
21954974
33.

Histopathologic findings of eyes enucleated after treatment with chemosurgery for retinoblastoma.

Graeber CP, Gobin YP, Marr BP, Dunkel IJ, Brodie SE, Bornfeld N, Char DH, Folberg R, Imhof SM, Lin AY, Berry JL, Al Mesfer S, Moll AC, Abramson DH.

Open Ophthalmol J. 2011 Jan 18;5:1-5. doi: 10.2174/1874364101105010001.

34.

[The sense and nonsense of waiting--waiting in ophthalmological practice].

Imhof SM, Ringens PJ.

Ned Tijdschr Geneeskd. 2010;154(51-52):A2877. Dutch.

PMID:
21211075
35.

Reproductive decision-making: a qualitative study among couples at increased risk of having a child with retinoblastoma.

Dommering CJ, van den Heuvel MR, Moll AC, Imhof SM, Meijers-Heijboer H, Henneman L.

Clin Genet. 2010 Oct;78(4):334-41. doi: 10.1111/j.1399-0004.2010.01484.x.

PMID:
20618349
36.

Brain abnormalities on MR imaging in patients with retinoblastoma.

Rodjan F, de Graaf P, Moll AC, Imhof SM, Verbeke JI, Sanchez E, Castelijns JA.

AJNR Am J Neuroradiol. 2010 Sep;31(8):1385-9. doi: 10.3174/ajnr.A2102. Epub 2010 Apr 22.

37.

Risk of third malignancies and death after a second malignancy in retinoblastoma survivors.

Marees T, van Leeuwen FE, Schaapveld M, Imhof SM, de Boer MR, Kors WA, Ringens PJ, Moll AC.

Eur J Cancer. 2010 Jul;46(11):2052-8. doi: 10.1016/j.ejca.2010.03.029. Epub 2010 Apr 17.

PMID:
20400293
38.

Contrast-enhancement of the anterior eye segment in patients with retinoblastoma: correlation between clinical, MR imaging, and histopathologic findings.

de Graaf P, van der Valk P, Moll AC, Imhof SM, Schouten-van Meeteren AY, Knol DL, Castelijns JA.

AJNR Am J Neuroradiol. 2010 Feb;31(2):237-45. doi: 10.3174/ajnr.A1825. Epub 2009 Oct 15.

39.

Incidence of retinoblastoma in Dutch children conceived by IVF: an expanded study.

Marees T, Dommering CJ, Imhof SM, Kors WA, Ringens PJ, van Leeuwen FE, Moll AC.

Hum Reprod. 2009 Dec;24(12):3220-4. doi: 10.1093/humrep/dep335. Epub 2009 Sep 25.

PMID:
19783550
40.

Restrictions in daily life after retinoblastoma from the perspective of the survivors.

van Dijk J, Oostrom KJ, Huisman J, Moll AC, Cohen-Kettenis PT, Ringens PJ, Imhof SM.

Pediatr Blood Cancer. 2010 Jan;54(1):110-5. doi: 10.1002/pbc.22230.

PMID:
19760766
41.

Re: More about second cancers after retinoblastoma.

Marees T, Moll AC, Imhof SM, de Boer MR, Ringens PJ, van Leeuwen FE.

J Natl Cancer Inst. 2010 Jun 2;102(11):831-2. doi: 10.1093/jnci/djp207. Epub 2009 Jul 20. No abstract available.

PMID:
19620600
42.

Cancer mortality in long-term survivors of retinoblastoma.

Marees T, van Leeuwen FE, de Boer MR, Imhof SM, Ringens PJ, Moll AC.

Eur J Cancer. 2009 Dec;45(18):3245-53. doi: 10.1016/j.ejca.2009.05.011. Epub 2009 Jun 1.

PMID:
19493675
43.

Coping strategies of retinoblastoma survivors in relation to behavioural problems.

van Dijk J, Grootenhuis MA, Imhof SM, Cohen-Kettenis PT, Moll AC, Huisman J.

Psychooncology. 2009 Dec;18(12):1281-9. doi: 10.1002/pon.1507.

PMID:
19222049
44.

Risk of second malignancies in survivors of retinoblastoma: more than 40 years of follow-up.

Marees T, Moll AC, Imhof SM, de Boer MR, Ringens PJ, van Leeuwen FE.

J Natl Cancer Inst. 2008 Dec 17;100(24):1771-9. doi: 10.1093/jnci/djn394. Epub 2008 Dec 9.

PMID:
19066271
45.

Behavioural functioning of retinoblastoma survivors.

van Dijk J, Oostrom KJ, Imhof SM, Moll AC, Schouten-van Meeteren AY, Bezemer PD, Huisman J.

Psychooncology. 2009 Jan;18(1):87-95. doi: 10.1002/pon.1381.

PMID:
18613302
46.

Subsequent tumors in retinoblastoma survivors: the role of the head and neck surgeon.

de Bree R, Moll AC, Imhof SM, Buter J, Leemans CR.

Oral Oncol. 2008 Oct;44(10):982-5. doi: 10.1016/j.oraloncology.2007.12.005. Epub 2008 Feb 15.

PMID:
18280773
47.

Health-related quality of life of child and adolescent retinoblastoma survivors in the Netherlands.

van Dijk J, Huisman J, Moll AC, Schouten-van Meeteren AY, Bezemer PD, Ringens PJ, Cohen-Kettenis PT, Imhof SM.

Health Qual Life Outcomes. 2007 Dec 3;5:65.

48.

International retinoblastoma staging system helps to bridge the gap.

Schouten-van Meeteren AY, van der Valk P, Moll AC, Imhof SM, de Graaf P, Siregar NCh, Darmiati S, Asih D, Gatot D, Tehuteru E, Simangunsong LB, Sitorus RS.

Pediatr Blood Cancer. 2008 Mar;50(3):733. No abstract available.

PMID:
17975798
49.

Retinal dysplasia mimicking intraocular tumor: MR imaging findings with histopathologic correlation.

de Graaf P, van der Valk P, Moll AC, Imhof SM, Schouten-van Meeteren AY, Castelijns JA.

AJNR Am J Neuroradiol. 2007 Oct;28(9):1731-3. Epub 2007 Sep 20.

50.

Eye size in retinoblastoma: MR imaging measurements in normal and affected eyes.

de Graaf P, Knol DL, Moll AC, Imhof SM, Schouten-van Meeteren AY, Castelijns JA.

Radiology. 2007 Jul;244(1):273-80.

PMID:
17581906

Supplemental Content

Loading ...
Support Center